163 related articles for article (PubMed ID: 21725290)
1. Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.
Samplaski MK; Heston W; Elson P; Magi-Galluzzi C; Hansel DE
Mod Pathol; 2011 Nov; 24(11):1521-9. PubMed ID: 21725290
[TBL] [Abstract][Full Text] [Related]
2. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
[TBL] [Abstract][Full Text] [Related]
3. PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Nouira Y; Oueslati R
Pathol Biol (Paris); 2014 Jun; 62(3):129-36. PubMed ID: 24745345
[TBL] [Abstract][Full Text] [Related]
4. Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma.
Jiao D; Li Y; Yang F; Han D; Wu J; Shi S; Tian F; Guo Z; Xi W; Li G; Zhao A; Yang AG; Qin W; Wang H; Wen W
Clin Transl Gastroenterol; 2019 May; 10(5):1-7. PubMed ID: 31116141
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers.
Haffner MC; Kronberger IE; Ross JS; Sheehan CE; Zitt M; Mühlmann G; Ofner D; Zelger B; Ensinger C; Yang XJ; Geley S; Margreiter R; Bander NH
Hum Pathol; 2009 Dec; 40(12):1754-61. PubMed ID: 19716160
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 expression in tumor cells and the immunologic milieu of bladder carcinomas: a pathologic review of 165 cases.
Davick JJ; Frierson HF; Smolkin M; Gru AA
Hum Pathol; 2018 Nov; 81():184-191. PubMed ID: 29969606
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.
Haffner MC; Laimer J; Chaux A; Schäfer G; Obrist P; Brunner A; Kronberger IE; Laimer K; Gurel B; Koller JB; Seifarth C; Zelger B; Klocker H; Rasse M; Doppler W; Bander NH
Mod Pathol; 2012 Aug; 25(8):1079-85. PubMed ID: 22460809
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy.
Wernicke AG; Kim S; Liu H; Bander NH; Pirog EC
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):271-276. PubMed ID: 26862945
[TBL] [Abstract][Full Text] [Related]
11. Well-Differentiated Thyroid Cancer Neovasculature Expresses Prostate-Specific Membrane Antigen-a Possible Novel Therapeutic Target.
Moore M; Panjwani S; Mathew R; Crowley M; Liu YF; Aronova A; Finnerty B; Zarnegar R; Fahey TJ; Scognamiglio T
Endocr Pathol; 2017 Dec; 28(4):339-344. PubMed ID: 28844117
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.
Wernicke AG; Varma S; Greenwood EA; Christos PJ; Chao KS; Liu H; Bander NH; Shin SJ
APMIS; 2014 Jun; 122(6):482-9. PubMed ID: 24304465
[TBL] [Abstract][Full Text] [Related]
13. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
Minner S; Wittmer C; Graefen M; Salomon G; Steuber T; Haese A; Huland H; Bokemeyer C; Yekebas E; Dierlamm J; Balabanov S; Kilic E; Wilczak W; Simon R; Sauter G; Schlomm T
Prostate; 2011 Feb; 71(3):281-8. PubMed ID: 20809553
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma.
Zeng C; Ke ZF; Yang Z; Wang Z; Yang SC; Luo CQ; Wang LT
Med Oncol; 2012 Sep; 29(3):2234-9. PubMed ID: 22009216
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
16. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
[TBL] [Abstract][Full Text] [Related]
17. Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies.
Ben Jemaa A; Bouraoui Y; Sallami S; Banasr A; Ben Rais N; Ouertani L; Nouira Y; Horchani A; Oueslati R
J Exp Clin Cancer Res; 2010 Dec; 29(1):171. PubMed ID: 21189143
[TBL] [Abstract][Full Text] [Related]
18. Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms.
Baccala A; Sercia L; Li J; Heston W; Zhou M
Urology; 2007 Aug; 70(2):385-90. PubMed ID: 17826525
[TBL] [Abstract][Full Text] [Related]
19. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
20. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
Chen W; Lee Z; Awadallah A; Zhou L; Xin W
Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
